| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.024 | 0.9 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |